We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+4.16%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$5.46B
AUM Growth
+$264M
Cap. Flow
+$147M
Cap. Flow %
2.69%
Top 10 Hldgs %
33.99%
Holding
157
New
31
Increased
42
Reduced
55
Closed
27

Top Buys

Rank Stock Value
1
BKNG icon
Booking.com
BKNG
+$90.4M
2
QRVO icon
Qorvo
QRVO
+$75.2M
3
META icon
Meta Platforms (Facebook)
META
+$52.4M
4
NVDA icon
NVIDIA
NVDA
+$45.8M
5
COF icon
Capital One
COF
+$42.3M

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$59M
2
MSFT icon
Microsoft
MSFT
+$55.4M
3
AMZN icon
Amazon
AMZN
+$50.3M
4
MRK icon
Merck
MRK
+$40.2M
5
ORCL icon
Oracle
ORCL
+$31.2M

Sector Composition

Rank Sector Weight
1 Utilities 27.87%
2 Technology 14.3%
3 Healthcare 11.52%
4 Consumer Discretionary 9.78%
5 Energy 8.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STE icon
101
Steris
STE
$22.8B
$128K ﹤0.01%
610
-2
-0.3% -$429
VRTX icon
102
Vertex Pharmaceuticals
VRTX
$137B
$117K ﹤0.01%
235
+108
+85% +$47.9K
WAT icon
103
Waters Corp
WAT
$40.7B
$103K ﹤0.01%
275
-95
-26% -$32.4K
JCI icon
104
Johnson Controls International
JCI
$84.6B
$101K ﹤0.01%
693
-365
-34% -$51.5K
UNH icon
105
UnitedHealth
UNH
$353B
$94.8K ﹤0.01%
+228
New +$84.5K
NTRA icon
106
Natera
NTRA
$47B
$87.4K ﹤0.01%
322
+42
+15% +$8.96K
ESTA icon
107
Establishment Labs
ESTA
$2.11B
$82.7K ﹤0.01%
+964
New +$69.3K
SIBN icon
108
SI-BONE Inc
SIBN
$861M
$81K ﹤0.01%
4,965
-599
-11% -$8.56K
ABT icon
109
Abbott
ABT
$195B
$66.6K ﹤0.01%
+734
New +$67K
AVA icon
110
Avista
AVA
$3.15B
$64K ﹤0.01%
1,565
-823
-34% -$33.9K
ADSK icon
111
Autodesk
ADSK
$55B
$59.7K ﹤0.01%
307
-13,151
-98% -$3M
GE icon
112
GE Aerospace
GE
$355B
$54.2K ﹤0.01%
145
+4
+3% +$1.25K
IR icon
113
Ingersoll Rand
IR
$30.5B
$50.8K ﹤0.01%
619
-325
-34% -$25.1K
MYRG icon
114
MYR Group
MYRG
$4.58B
$48.5K ﹤0.01%
97
-214
-69% -$87.9K
HUM icon
115
Humana
HUM
$46.3B
$44.5K ﹤0.01%
+112
New +$31.9K
ELAN icon
116
Elanco Animal Health
ELAN
$12B
$42.3K ﹤0.01%
+1,720
New +$39.8K
ORA icon
117
Ormat Technologies
ORA
$6.34B
$38.6K ﹤0.01%
354
-186
-34% -$23.1K
THC icon
118
Tenet Healthcare
THC
$21.5B
$38K ﹤0.01%
+203
New +$37.3K
DNTH icon
119
Dianthus Therapeutics
DNTH
$5.92B
$36.9K ﹤0.01%
379
+15
+4% +$1.31K
QGEN icon
120
Qiagen
QGEN
$8.9B
$36.8K ﹤0.01%
940
-1,049
-53% -$39K
MASS icon
121
908 Devices
MASS
$444M
$34.7K ﹤0.01%
3,994
-408
-9% -$3.13K
EW icon
122
Edwards Lifesciences
EW
$52B
$34.3K ﹤0.01%
+379
New +$31.7K
CI icon
123
Cigna
CI
$73.7B
$34.2K ﹤0.01%
+124
New +$35K
BIO icon
124
Bio-Rad Laboratories Class A
BIO
$10.4B
$33.2K ﹤0.01%
+113
New +$32.1K
MCK icon
125
McKesson
MCK
$104B
$32.5K ﹤0.01%
+43
New +$34.1K
3 4
5
6 7

Similar funds

ENV
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $5.44B AUM 27.71% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Antipodes Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Antipodes Partners held 157 positions worth $5.46B, up 5.1% from $5.19B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Antipodes Partners's Q2 2026 filing shows 31 new, 42 increased, 55 reduced and 27 closed positions. Its largest new stake was Booking.com: 530,062 shares worth $94.2M. The largest sale was Workday, an estimated $59M.

By sector, the portfolio is most concentrated in Utilities at 28% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Antipodes Partners's largest Q2 2026 buy was Booking.com: 530,062 shares worth $94.2M.
  • Antipodes Partners added most to Meta Platforms (Facebook) in Q2 2026, an estimated $52.4M increase.
  • Antipodes Partners's biggest Q2 2026 reduction was Workday, cutting an estimated $59M.
  • Antipodes Partners fully exited Oracle in Q2 2026, selling an estimated $31.2M.
  • Antipodes Partners's ten largest holdings make up 34% of its $5.46B portfolio in Q2 2026.
  • Antipodes Partners opened 31 new positions and closed 27 in Q2 2026.
  • Antipodes Partners's portfolio value rose 5.1% quarter-over-quarter to $5.46B.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.